Medium-term Clinical Efficacy and Complications of Plasmakinetic Enucleation of the Prostate Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia - 13/06/22
Editor: Dr. E. Klein
ABSTRACT |
Objective |
To compare surgical characteristics, clinical efficacy, and complications of plasmakinetic enucleation of the prostate (PKEP) and transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH).
Materials and Methods |
From January 2015 to May 2018, 370 patients underwent TURP were included into the TURP group. Meanwhile, another 370 patients underwent PKEP (matched by age, prostate volume, and duration of BPH) were included into the PKEP group. Then, the differences of surgical characteristics, clinical efficacy, and complications were compared between the two groups.
Results |
The operative time, intraoperative irrigation volume, postoperative irrigation time and irrigation volume, drop in hemoglobin, blood transfusion, postoperative catheterization time, and hospital stay of the PKEP group were significantly less than those of the TURP group (P <.05). No significant differences were observed in the resected tissue weight, visual analogue scale score, and total cost of hospitalization (P >.05); The quality of life score of the PKEP group was significantly lower than that of the TURP group (P <.05). No significant differences of maximum flow rate, postvoid residual urine, Serum prostate-specific antigen, international prostate symptom score and International Index of Erectile Function score were observed (P >.05); The incidences of urinary tract irritation, massive hemorrhage, secondary hemorrhage, bladder spasm, clot retention, and retrograde ejaculation of the PKEP group were significantly lower than those of the TURP group (P <.05).
Conclusion |
PKEP and TURP are comparable regarding cost burden and clinical efficacy in medium-term follow-up. However, PKEP should be given a priority for BPH treatment because of less complication rate and better safety profile.
Le texte complet de cet article est disponible en PDF.Plan
| Funding: This work was supported by the Science and Technology Project of Traditional Chinese Medicine of Zhejiang Province, China (No. 2022ZB326). |
Vol 164
P. 204-210 - juin 2022 Retour au numéro
Article précédent
- AUTHOR REPLY
- Li June Tay, Meghana Kulkarni, Akinlolu Oluwole-Ojo, Leigh James Spurling, Oussama El-hage, Ella DiBenedetto, Marios Hadjipavlou, Rick Popert, Ben Challacombe
- Evaluating Patient Preferences in Benign Prostatic Hyperplasia Treatment Using Conjoint Analysis
- Phillip J. Huffman, Edward Yin, Andrew J. Cohen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?